Safety and efficacy of the RTS,S/AS01_E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKWAKU POKU ASANTE; ABDULLA, Salim; SALIM, Nahya et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 741-749, issn 1473-3099, 9 p.Article

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01_E Malaria Candidate Vaccine When Integrated in the Expanded Program of ImmunizationAGNANDJI, Selidji T; ASANTE, Kwaku Poku; CHIKAWE, Maria et al.The Journal of infectious diseases. 2010, Vol 202, Num 7, pp 1076-1087, issn 0022-1899, 12 p.Article

Pharmacokinetic and Pharmacodynamic Characteristics of a New Pediatric Formulation of Artemether-Lumefantrine in African Children with Uncomplicated Plasmodium falciparum MalariaDJIMDE, Abdoulaye A; TEKETE, Mamadou; ABDULLA, Salim et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 9, pp 3994-3999, issn 0066-4804, 6 p.Article

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria : a randomised, single-blind, multicentre trial. CommentaryTEKLEHAIMANOT, Awash; TEKLEHAIMANOT, Hailay Desta; LYIMO, John et al.Lancet (British edition). 2008, Vol 372, Num 9652, issn 0140-6736, 1786-1787, 1819-1827 [11 p.]Article